Vascular endothelial growth factor expression in pituitary adenomas

Acta Neurochir Suppl. 2003:86:519-21. doi: 10.1007/978-3-7091-0651-8_106.

Abstract

Vascular endothelial growth factor (VEGF) is known to be a mediator of angiogenesis and vascular permeability. A cystic component and hemorrhage are often found in pituitary adenomas. In the present study we assess the VEGF expression based on immunohistochemical examinations in 48 pituitary adenomas. All the adenomas showed some VEGF immunoreactivity mainly in the cytoplasm of tumor cells. Of the 48 adenoma-cases, 16 cases had a strong VEGF immunoreactivity, 26 cases had a moderate one, and 6 cases had a weak one. On the MR images, a cystic component was found in 16 cases (33.3%), and a hemorrhage was found in 18 cases (37.5%). The VEGF immunoreactivity had a significant relationship with the cystic component but neither the hemorrhage, size, recurrence, or HE classification. These findings suggest that VEGF might play a potential role in the pathogenesis of cystic formation in pituitary adenomas.

MeSH terms

  • Adenoma / diagnosis
  • Adenoma / metabolism*
  • Adenoma / pathology
  • Adolescent
  • Adult
  • Aged
  • Cysts / metabolism
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pituitary Neoplasms / diagnosis
  • Pituitary Neoplasms / metabolism*
  • Pituitary Neoplasms / pathology
  • Retrospective Studies
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Vascular Endothelial Growth Factor A